首页 | 本学科首页   官方微博 | 高级检索  
     


Surprise Questions for Survival Prediction in Patients With Advanced Cancer: A Multicenter Prospective Cohort Study
Authors:Jun Hamano  Tatsuya Morita  Satoshi Inoue  Masayuki Ikenaga  Yoshihisa Matsumoto  Ryuichi Sekine  Takashi Yamaguchi  Takeshi Hirohashi  Tsukasa Tajima  Ryohei Tatara  Hiroaki Watanabe  Hiroyuki Otani  Chizuko Takigawa  Yoshinobu Matsuda  Hiroka Nagaoka  Masanori Mori  Naoki Yamamoto  Mie Shimizu  Takeshi Sasara  Hiroya Kinoshita
Affiliation:1. Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan;2. Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, Hamamatsu, Japan;3. Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu City, Japan;4. Hospice Children's Hospice Hospital, Yodogawa Christian Hospital, Osaka, Japan;5. Department of Palliative Medicine, National Cancer Center Hospital East, Kashiwa, Japan;6. Department of Pain and Palliative Care, Kameda Medical Center, Kamogawa, Japan;7. Department of Palliative Medicine, Kobe University Graduate School of Medicine, Kobe, Japan;8. Department of Palliative Care, Mitui Memorial Hospital, Tokyo, Japan;9. Department of Palliative Medicine, Tohoku University Hospital, Sendai, Japan;10. Department of Palliative Medicine, Osaka City General Hospital, Osaka, Japan;11. Komaki City Hospital, Komaki, Japan;12. Department of Palliative Care Team, and Palliative and Supportive Care, National Kyushu Cancer Center, Fukuoka, Japan;13. Department of Palliative Care, KKR Sapporo Medical Center, Sapporo, Japan;14. Department of Psychosomatic Medicine, National Hospital Organization Kinki‐Chuo Chest Medical Center, Osaka, Japan;15. Center for Palliative and Supportive Care, Tsukuba University Hospital, Ibaraki, Japan;16. Seirei Hamamatsu General Hospital, Hamamatsu, Japan;17. Department of Primary Care Service, Shinsei Hospital, Nagano, Japan;18. Saiseikai Matsusaka General Hospital, Matsusaka, Japan;19. Yuuaikai Nanbu Hospital, Itoman, Japan;20. Department of Palliative Medicine, National Cancer Center Hospital East, Chiba, Japan
Abstract:

Background.

Predicting the short-term survival in cancer patients is an important issue for patients, family, and oncologists. Although the prognostic accuracy of the surprise question has value in 1-year mortality for cancer patients, the prognostic value for short-term survival has not been formally assessed. The primary aim of the present study was to assess the prognostic value of the surprise question for 7-day and 30-day survival in patients with advanced cancer.

Patients and Methods.

The present multicenter prospective cohort study was conducted in Japan from September 2012 through April 2014, involving 16 palliative care units, 19 hospital-based palliative care teams, and 23 home-based palliative care services.

Results.

We recruited 2,425 patients and included 2,361 for analysis: 912 from hospital-based palliative care teams, 895 from hospital palliative care units, and 554 from home-based palliative care services. The sensitivity, specificity, positive predictive value, and negative predictive value of the 7-day survival surprise question were 84.7% (95% confidence interval [CI], 80.7%–88.0%), 68.0% (95% CI, 67.3%–68.5%), 30.3% (95% CI, 28.9%–31.5%), and 96.4% (95% CI, 95.5%–97.2%), respectively. The sensitivity, specificity, positive predictive value, and negative predictive value for the 30-day surprise question were 95.6% (95% CI, 94.4%–96.6%), 37.0% (95% CI, 35.9%–37.9%), 57.6% (95% CI, 56.8%–58.2%), and 90.4% (95% CI, 87.7%–92.6%), respectively.

Conclusion.

Surprise questions are useful for screening patients for short survival. However, the high false-positive rates do not allow clinicians to provide definitive prognosis prediction.

Implications for Practice:

The findings of this study indicate that clinicians can screen patients for 7- or 30-day survival using surprise questions with 90% or more sensitivity. Clinicians cannot provide accurate prognosis estimation, and all patients will not always die within the defined periods. The screened patients can be regarded as the subjects to be prepared for approaching death, and proactive discussion would be useful for such patients.
Keywords:Surprise questions  Prognostic value  7‐day survival  30‐day survival  Advanced cancer
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号